XML 34 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 12 - Stock-based Compensation
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
12
– STOCK-BASED COMPENSATION
 
Stock-based compensation plans are used to provide directors and employees with an increased incentive to contribute to our long-term performance and growth, to align
the interests of directors and employees with the interests of our shareholders through the opportunity for increased stock ownership and to attract and retain directors and employees. During
2014
and
2015,
stock option and restricted stock grants were provided to certain employees through the Stock Incentive Plan of
2006.
During
2016
and
2017,
restricted stock grants were provided to certain employees through the Stock Incentive Plan of
2016.
Stock option grants were also provided to certain employees during
2016
through the Stock Incentive Plan of
2016.
Stock grants were provided to directors as retainer payments during
2014
and
2015
through the Stock Incentive Plan of
2006,
and during
2016
and
2017
through the Stock Incentive Plan of
2016.
The Stock Incentive Plan of
2006
expired on
January 18, 2016,
and was effectively replaced with the Stock Incentive Plan of
2016
that was approved by shareholders in
May, 2016.
 
Under the Stock Incentive Plan of
2006
and the Stock Incentive Plan of
2016,
incentiv
e awards
may
include, but are
not
limited to, stock options, restricted stock, stock appreciation rights and stock awards. Incentive awards that are stock options or stock appreciation rights are granted with an exercise price
not
less than the closing price of our common stock on the date of grant. Price, vesting and expiration date parameters are determined by Mercantile’s Compensation Committee on a grant-by-grant basis.
No
payments are required from employees for restricted stock awards. The restricted stock awards granted during
2014,
2015,
2016
and
2017
fully vest after
three
years. The stock options granted during
2014,
2015
and
2016,
which were at
110%
of the market price on the date of grant, fully vest after
two
years and expire after
seven
years. At year-end
2017,
there were approximately
314,000
shares authorized for future incentive awards.
 
In conjunction with the Firstbank merger, all of our outstanding restricted stock awards, which were scheduled to vest in full in
November, 2014,
becam
e fully vested on
June 1, 2014.
The unrecognized compensation cost related to restricted stock grants was
$5.7
million as of
December 31, 2017,
which will be recognized as expense over the next
three
years.
 
Also in conjunction with the Firstbank merger,
we issued Mercantile stock options in replacement of all outstanding Firstbank stock option grants that had been previously issued to Firstbank employees under the Firstbank Corporation Stock Option and Restricted Stock Plan of
1997
and the Firstbank Corporation
2006
Stock Compensation Plan. In general, stock option grants for
50
shares or less fully vested after
one
year from date of grant, while stock option grants for more than
50
shares vested over a
five
-year period at
20%
of the grant per annum starting
one
year from date of grant. The stock option grants expire
ten
years from date of grant. There were approximately
282,200
Mercantile stock options issued as a result of the merger, with about
258,400
of the stock option grants fully vested and exercisable on the date of merger. The remaining
23,800
stock option grants vested during
2015.
 
A summary of restricted stock activity from grants issued under Mercantile plans during the past
three
years is as follows:
 
   
2017
   
2016
   
2015
 
   
Shares
   
Weighted
Average
Fair Value
   
Shares
   
Weighted
Average
Fair Value
   
Shares
   
Weighted
Average
Fair Value
 
                                                 
Nonvested at beginning of year
   
228,343
    $
26.09
     
155,501
    $
22.25
     
101,490
    $
20.13
 
Granted
   
94,592
     
37.11
     
86,250
     
32.19
     
65,933
     
25.14
 
Vested
   
(74,979
)
   
20.17
     
(7,622
)
   
20.23
     
(4,666
)
   
20.13
 
Forfeited
   
(8,319
)
   
23.75
     
(5,786
)
   
21.90
     
(7,256
)
   
20.13
 
Nonvested at end of year
   
239,637
    $
32.37
     
228,343
    $
26.09
     
155,501
    $
22.25
 
 
 
 
A summary of stock option activity
from grants issued under Mercantile plans during the past
three
years is as follows:
 
   
2017
   
2016
   
2015
 
   
Shares
   
Weighted
Average
Exercise
Price
   
Shares
   
Weighted
Average
Exercise
Price
   
Shares
   
Weighted
Average
Exercise
Price
 
                                                 
Outstanding at beginning of year
   
16,808
    $
29.17
     
11,308
    $
24.50
     
35,335
    $
31.09
 
Granted
   
0
   
 
NA
     
6,500
     
36.22
     
4,820
     
27.66
 
Exercised
   
(1,000
)
   
22.15
     
(1,000
)
   
22.15
     
(2,700
)
   
6.21
 
Forfeited or expired
   
0
   
 
NA
     
0
   
 
NA
     
(26,147
)
   
35.88
 
Outstanding at end of year
   
15,808
    $
29.62
     
16,808
    $
29.17
     
11,308
    $
24.50
 
Options exercisable at year-end    
9,308
    $
25.00
     
5,488
    $
22.15
     
0
    $
NA
 
 
 
The fair value of each stock option award is estimated on the date of grant using a closed option
valuation (Black-Scholes) model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatilities on our common stock. Historical data is used to estimate stock option expense and post-vesting termination behavior. The expected term of stock options granted is based on historical data and represents the period of time that stock options granted are expected to be outstanding, which takes into account that the stock options are
not
transferable. The risk-free interest rate for the expected term of the stock option is based on the U.S. Treasury yield curve in effect at the time of the stock option grant.
 
 
The fair value of stock options granted during
2016
and
2015
was determined using the following weighted-a
verage assumptions as of the grant date.
No
stock options were granted in
2017.
    
   
2016
   
2015
 
                 
Risk-free interest rate
   
1.78
%    
1.67
%
Expected option life (years)
   
5
     
5
 
Expected stock price volatility
   
26
%    
29
%
Dividend yield
   
2.5
%    
2.5
%
Options issued under Mercantile plans outstanding at year-end
201
7
were as follows:
 
 
       
Outstanding
   
Exercisable
 
               
Weighted
Average
   
Weighted
           
Weighted
 
Range of
   
 
   
Remaining
   
Average
     
 
   
Average
 
Exercise
   
 
   
Contractual
   
Exercise
     
 
   
Exercise
 
Prices
 
Number
   
Life (Years)
   
Price
   
Number
   
Price
 
                                             
$20.0
0
$24.00
   
4,488
     
3.9
    $
22.15
     
4,488
     
22.15
 
$24.01
$28.00
   
4,820
     
4.9
     
27.66
     
4,820
     
27.66
 
$36.00
$40.00
   
6,500
     
5.9
     
36.22
     
0
   
NA
 
Outstanding at year end
   
15,808
     
5.0
    $
29.62
     
9,308
     
25.00
 
 
 
Information related to options issued under various Mercantile plans outstanding at year-end
201
7,
2016
and
2015
is as follows:
 
   
   
201
7
   
201
6
   
201
5
 
                         
Minimum exercise price
  $
22.15
    $
22.15
    $
22.15
 
Maximum exercise price
   
36.22
     
36.22
     
27.66
 
Average remaining option term (y
ears)
   
5.0
     
6.7
     
6.3
 
 
 
Information related to stock option grants and exercises issued under various
Mercantile plans during
2017,
2016
and
2015
is as follows:
 
   
   
201
7
   
201
6
   
201
5
 
                         
Aggregate intrinsic value of stock options exercised
  $
15,000
    $
6,000
    $
36,000
 
Cash received from stock option exercises
   
0
     
22,000
     
17,000
 
Tax benefit realized from stock option exercises
   
0
     
0
     
0
 
Weighted average per share fair value of stock options granted
   
2.72
     
5.25
     
4.41
 
 
 
The aggregate intrinsic value of all stock options
issued under Mercantile plans outstanding and exercisable at
December 31, 2017
was
$0.1
million. Shares issued as a result of the exercise of stock option grants have been authorized and were previously unissued shares.
A summary of stock option activity from grants issued under Firstbank plans that became part of Mercantile
’s plans upon consummation of the merger on
June 1, 2014
is as follows:
 
   
201
7
   
201
6
   
201
5
 
   
Shares
   
Weighted
Average
Exercise
Price
   
Shares
   
Weighted
Average
Exercise
Price
   
Shares
   
Weighted
Average
Exercise
Price
 
                                                 
Outstanding at beginning of year
   
44,275
    $
9.86
     
123,887
    $
12.64
     
217,982
    $
14.89
 
Granted
   
0
   
NA
     
0
   
NA
     
0
   
NA
 
Exercised
   
(27,675
)
   
11.50
     
(71,711
)
   
13.33
     
(56,417
)
   
15.50
 
Forfeited or expired
   
(1,500
)
   
6.33
     
(7,901
)
   
22.00
     
(37,678
)
   
21.39
 
Outstanding at end of year
   
15,100
    $
7.20
     
44,275
    $
9.86
     
123,887
    $
12.64
 
Options exercisable at year-end
   
15,100
    $
7.20
     
44,275
    $
9.86
     
123,887
    $
12.64
 
 
 
 
Options issued under Firstbank plans outstanding at year-end
201
7
were as follows:
 
 
       
Outstanding
   
Exercisable
 
               
Weighted
Average
   
Weighted
           
Weighted
 
Range of
   
 
   
Remaining
   
Average
     
 
   
Average
 
Exercise
   
 
   
Contractual
   
Exercise
     
 
   
Exercise
 
Prices
 
Number
   
Life (Years)
   
Price
   
Number
   
Price
 
                                             
$4.00
$8.00
   
12,400
     
1.6
    $
6.89
     
12,400
    $
6.89
 
$
8.01
$12.00
   
2,700
     
1.9
     
8.60
     
2,700
     
8.60
 
Outstanding at year end
   
15,100
     
1.7
    $
7.20
     
15,100
    $
7.20
 
 
 
Information related to options issued under Firstbank plans outstanding at year-end
2017,
2016
and
2015
is as follows:
 
   
   
201
7
   
201
6
   
201
5
 
                         
Minimum exercise price
  $
6.89
    $
5.19
    $
5.19
 
Maximum exercise price
   
8.60
     
16.00
     
22.00
 
Average remaining option term (years)
   
1.7
     
1.8
     
2.7
 
Information related to stock option grants and exercises issued under Firstbank plans during
2017,
2016
and
2015
is as follows:
   
201
7
   
201
6
   
201
5
 
                         
Aggregate intrinsic value
of stock options exercised
  $
594,000
    $
1,945,000
    $
420,000
 
Cash received from stock option exercises
   
318,000
     
956,000
     
874,000
 
Tax benefit realized from stock option exercises
   
208,000
     
681,000
     
147,000
 
Weighted average per share fair value of stock options granted
 
NA
   
NA
   
NA
 
 
The aggregate intrinsic value of all stock options issued under various Firstbank plans outstanding and exercisable at
December 31,
201
7
was
$0.4
million. Shares issued as a result of the exercise of stock option grants have been authorized and previously unissued shares.
 
On
January 2, 2015,
we granted a
bout
6,000
shares of common stock to our Corporate, Bank and Regional Advisory Boards of Directors for retainer payments for the period of
January 1, 2015
through
May 31, 2015.
The associated
$0.1
million cost was expensed on a straightline basis over the
first
five
months of
2015.
On
May 28, 2015,
we granted about
14,000
shares of common stock to our Corporate, Bank and Regional Advisory Boards of Directors for retainer payments for the period of
June 1, 2015
through
May 31, 2016.
The associated
$0.3
million cost was expensed on a straightline basis over the respective
twelve
month period. On
June 6, 2016,
we granted about
13,000
shares of common stock to our Corporate, Bank and Regional Advisory Boards of Directors for retainer payments for the period of
June 1, 2016
through
May 31, 2017.
The associated
$0.3
million cost was expensed on a straightline basis over the respective
twelve
month period. On
May 25, 2017,
we granted about
12,000
shares of common stock to our Corporate, Bank and Regional Advisory Boards of Directors for retainer payments for the period of
June 1, 2017
through
May 31, 2018.
The associated
$0.4
million is being expensed on a straightline basis over the respective
twelve
month period.